06/01/2021

Beck's Advances Breeding Program Through Continued Partnership with Computomics

Beck's, the largest family-owned retail seed company in the United States, is proud to expand their collaboration with Computomics, a biotechnology company in Tübingen, G...
06/02/2021

Preliminary results from RCT study show that OTSC first-line treatment is superior to standard treatment for acute non-varicose upper GI bleeding with high risk of rebleeding

In this week's news you can find the summary of the presentation on the STING II study by Prof. K. Caca, Ludwigsburg at the DGE-BV 2021. To read the news in German please...
06/02/2021

CureVac Appoints Klaus Edvardsen as Chief Development Officer

06/02/2021

CureVac ernennt Klaus Edvardsen zum Chief Development Officer

05/28/2021

Internationale Studie entdeckt neue Viren- und Bakterienstämme

Aktuell in Fachzeitschrift Cell publiziert Eine gemeinsame Mikrobiom-Studie des Instituts für Medizinische Genetik und Angewandte Genomik des Universitätsklinikums Tübingen und der Weill Cornell Grad...
05/28/2021

CureVac’s First-Generation COVID-19 Vaccine Candidate, CVnCoV, Continues Toward Phase 2b/3 Efficacy Readout in Variant-rich Environment Following DSMB Recommendation

Study continues to progress according to protocol following first interim analysis at 59 eligible COVID-19 cases Sequencing data to be made available in parallel with ef...
05/28/2021

CureVacs Impfstoffkandidat der ersten Generation, CVnCoV, setzt nach DSMB-Empfehlung in Phase 2b/3 Wirksamkeitsnachweis in variantengeprägtem Umfeld fort

Klinische Studie macht gemäß Studienprotokoll nach erster Zwischenanalyse auf Basis von 59 geprüften COVID-19-Fällen weiterhin Fortschritte Sequenzierdaten werden aufgru...